NCT02170844View on ClinicalTrials.gov

Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

August 31, 2004

Conditions
Healthy
Interventions
DRUG

BIBR 1048 MS

DRUG

Placebo of BIBR 1048 MS

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02170844 - Safety, Pharmacokinetics and Pharmacodynamics After Single Rising Oral Doses of BIBR 1048 MS as Capsules in Healthy Subjects of Japanese and Caucasian Origin | Biotech Hunter | Biotech Hunter